Search for: "Watson Pharmaceuticals"
Results 301 - 320
of 359
Sort by Relevance
|
Sort by Date
9 Aug 2009, 10:02 pm
Watson Pharmaceuticals, Inc. [read post]
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb) General Pharmaceutical patent settlements under fire on both sides of the Atlantic (GenericsWeb)… [read post]
29 Jul 2009, 6:45 am
Tafas v Doll (Patent Docs) US: For stem cells, it seems that conception is enough: University of Pittsburgh v Hedrick (Patent Docs) (Patents4Life) US: General Accountability Office report on Bayh-Dole: Leverage to promote commercialisation of federally-funded inventions (PatentBIOtech) US: AlphaVax seeks review of BPAI decision awarding priority of invention to Novartis in interference between patents related to Alphavirus (Patent Docs) US: Teva, Taro lobby US legislators on biogenerics… [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
26 Jun 2009, 6:47 am
Week one of trial will conclude this week in Alabama (Montgomery County Circuit Court) in the state's prosecution of drug company Watson Pharmaceuticals for overpricing. [read post]
17 Jun 2009, 3:21 pm
Watson Pharmaceuticals said Wednesday that it would buy the privately held Arrow Group for $1.75 billion in a deal that will help Watson to expand internationally. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent Docs)… [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent Docs) (Patent… [read post]
20 May 2009, 5:18 am
(IP tango) China: China IP forum to bring third patent amendment face-to-face with biotechnology concerns (PatentlyBIOtech) France: Patent and SPC status searches on the INPI website (The SPC Blog) India: Government republishes controversial report on patentability of pharmaceuticals and microorganisms (Managing Intellectual Property) India: The pharmaceutical patent debate: wither drug safety? [read post]
18 May 2009, 5:24 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: China and UK to fast track green patent applications, according to British IP minister (IAM) (IPKat) (Intellectual Property Watch) Golan case may put US in violation of international copyright treaties (Intellectual Property Watch) Taylor Wessing releases Global IP Index 2009 (IP Think Tank) (Managing Intellectual Property) (IP Dragon) (IAM)… [read post]
1 May 2009, 9:00 am
(IAM) US: Johnson & Johnson – 5 year exclusivity period would kill incentives to innovate (Patent Docs) US: CHI CEO on patent reform and follow-on biologics legislation (Patent Docs) US: BIO urges Congress on patent reform: First, do no harm (Patent Baristas) US: Pharmaceutical advertising: How to use a domain name to circumvent application of law (Domain Name / Nom De Domaine!) [read post]
9 Apr 2009, 9:14 pm
District Court for the District of Delaware has ruled that Watson Pharmaceuticals, Inc.'s generic version of Concerta ® (methylphenidate hydrochloride extended-release tablets) does not infringe ALZA Corporation's and McNeill-PPC's patent covering the drug. [read post]
9 Apr 2009, 7:52 am
(Part I - Patent Circle) (Part II – Patent Circle) Indian biogenerics on an upswing – US Promoting Innovation and Access to Life-Saving Medicine Act (Patent Baristas) US: Anti-reverse payment legislation Protecting Consumer Access to Generic Drugs Act of 2009 introduced in the House (Patent Docs) US: CAFC clarifies obviousness standard in context of cDNA cloning invention: In re Kubin (Holman's Biotech IP Blog) (Patent Docs) (Hal Wegner) (Philip Brooks' Patent… [read post]
25 Mar 2009, 12:17 pm
From the March 25 MedWatch Alert: FDA and Watson Pharmaceuticals notified healthcare professionals and patients of a recall of Propafenone HCL 225 mg tablets, a drug product used to treat cardiac arrhythmias. [read post]
13 Mar 2009, 2:00 am
(Patent Baristas) US: Schering merger includes legal headaches for Merck, including IP suits (Law360) US: Lessig and Eisen article ‘Is John Conyers Shilling for Special Interests’ concerning proposal to ban open access publishing requirement for taxpayer funded medical scientists (Huffington Post) (Lessig) (Lenz Blog) (Lessig) (Lenz Blog) (Michigan Messenger) (Lessig) US: McCain touts drug imports to lower US costs (Law360) US: Biotech and pharma provide little support in… [read post]
FTC and California AG Join in Challenging Reverse Payment Settlements in the Pharmaceutical Industry
6 Mar 2009, 7:03 am
The complaint also names generic pharmaceutical companies Watson Pharmaceuticals, Par Pharmaceuticals and Paddock Laboratories. [read post]
17 Feb 2009, 2:40 am
For example, the DNA sequence of James Watson, who helped discover DNA, was found to possess a sequence for Alzheimer’s. [read post]
13 Feb 2009, 5:00 am
(PharmaLittle) US: PerkinElmer sues Interna to invalidate down syndrome test patent (Law360) US: Monsanto files patent suit against Michigan farmers Earl and Richard Schroeder accusing them of planting pesticide-resistant seeds without paying proper royalties (Law360) US: Case to watch: preclusive effect of prior claim construction: Shire v Sandoz (Patently-O) Products AndroGel (Testosterone) - US: Federal Trade Commission continues campaign against reverse payments, filing complaint… [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
3 Feb 2009, 2:55 pm
The Federal Trade Commission has filed a complaint in federal district court challenging agreements by Solvay Pharmaceuticals, which paid generic drug makers Watson Pharmaceuticals and Par Pharmaceutical Companies to delay launching generic versions of Solvay's brand name testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. [read post]
